Related Experiment Video
Updated: Aug 30, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
The Trajectory of Epigenetic Chromatin Remodeling in Cardiometabolic Disease and its Therapeutic Implications
Mirjana Macvanin1, Aleksandra Klisic2,3
1Institute of Chemistry, Technology and Metallurgy, Center for Chemistry, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Abstract:
The pathogenesis and progression of cardiometabolic diseases (CMD) are intricately linked to epigenetic regulation mediated by chromatin remodeling. Modifications to histones, such as post-translational acetylation and methylation, along with DNA methylation, alter chromatin structure and accessibility, resulting in transient or irreversible alterations in gene expression without accompanying changes in the DNA sequence. Herein, we outline the trajectory of epigenetic chromatin remodeling across various tissues, focusing on the liver-heart axis and the crosstalk between various epigenetic mechanisms in CMD pathogenesis and progression. We provide a list of drugs that target crucial epigenetic enzymes for CMD treatment. Furthermore, we propose possible future directions for the development of effective therapies targeting the crosstalk interaction points of epigenetic mechanisms involved in CMD.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Coronary Artery Disease I: Introduction
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...